Many health plans are addressing rapid genetic testing growth with utilization management (UM) programs, such as prior authorization. But, some key areas of inappropriate genetic testing cost are often overlooked: overbilling, and subsequent overpayment for genetic tests.
Based on our actual client work with many of the nation’s largest health plans — as well as the expertise of the nation’s largest independent organization of genetics specialists — we’ve identified a number of factors that contribute to higher-than-necessary costs for genetic testing.
This guide explores ways that payers can better identify and reduce unnecessary claims payments related to genetic testing by:
Building automated claims edits and payment rules into your claims processing system
Conducting analyses of genetic testing claims trends
Using the results of claims analyses to strengthen lab contract negotiations
Regularly monitoring genetic test claims to assess progress and pinpoint additional opportunities for improvement
Just fill out the form below to download your copy now.